000 01556 a2200457 4500
005 20250513135247.0
264 0 _c19980331
008 199803s 0 0 eng d
022 _a0163-4356
024 7 _a10.1097/00007691-199802000-00001
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBathum, L
245 0 0 _aA dual label oligonucleotide ligation assay for detection of the CYP2C19*1, CYP2C19*2, and CYP2C19*3 alleles involving time-resolved fluorometry.
_h[electronic resource]
260 _bTherapeutic drug monitoring
_cFeb 1998
300 _a1-6 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAlleles
650 0 4 _aAryl Hydrocarbon Hydroxylases
650 0 4 _aAsian People
_xgenetics
650 0 4 _aCytochrome P-450 CYP2C19
650 0 4 _aCytochrome P-450 Enzyme System
_xanalysis
650 0 4 _aDenmark
_xepidemiology
650 0 4 _aEuropium
650 0 4 _aFemale
650 0 4 _aFluorometry
_xmethods
650 0 4 _aGenotype
650 0 4 _aHumans
650 0 4 _aLanthanum
650 0 4 _aMale
650 0 4 _aMixed Function Oxygenases
_xanalysis
650 0 4 _aOligonucleotide Probes
650 0 4 _aPhenotype
650 0 4 _aPolymerase Chain Reaction
650 0 4 _aSamarium
650 0 4 _aWhite People
_xgenetics
700 1 _aHansen, T S
700 1 _aHørder, M
700 1 _aBrøsen, K
773 0 _tTherapeutic drug monitoring
_gvol. 20
_gno. 1
_gp. 1-6
856 4 0 _uhttps://doi.org/10.1097/00007691-199802000-00001
_zAvailable from publisher's website
999 _c9453714
_d9453714